Investor Presentation December 2022

Disclaimers This presentation and oral statements made regarding the subject of this presentation contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. Such statements include, without limitation, references to the Steakholder Foods Ltd.’s (the “Company”, "we" or "our") predictions or expectations of future business or financial performance and its goals and objectives for future operations, financial and business trends, performances, strategies or expectations. In some cases, you can identify forward-looking statements by the words “may,” “might,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “objective,” “anticipate,” “believe,” “estimate,” “predict”, “potential,” “continue” and “ongoing,” or the negative of these terms, or other comparable terminology intended to identify statements about the future and include, without limitation, Steakholder Foods’ expectations regarding the success of its cultured meat manufacturing technologies it is developing, which will require significant additional work before Steakholder Foods can potentially launch commercial sales; Steakholder Foods’ research and development activities associated with technologies for cultured meat manufacturing, including three-dimensional meat production, which involves a lengthy and complex process; Steakholder Foods’ ability to obtain and enforce its intellectual property rights and to operate its business without infringing, misappropriating, or otherwise violating the intellectual property rights and proprietary technology of third parties; and other risks and uncertainties, including those listed in the section titled “Risk Factors” in a registration statement on Form F-1 (File No. 333-268559), including a preliminary prospectus, dated December 5, 2022, filed with the U.S. Securities and Exchange Commission on December 5, 2022 These forward-looking statements may not materialize, in whole or in part, or may materialize differently than expected, or may be affected by factors that cannot be assessed in advance. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. You are cautioned not to place undue reliance on forward-looking statements. Except as otherwise indicated, the forward-looking statements contained in this presentation speak only as of the date of this presentation and the Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. This presentation includes statistical, market and industry data and forecasts which we obtained from publicly available information and independent industry publications and reports that we believe to be reliable sources. These publicly available industry publications and reports generally state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the information. Although we are responsible for all of the disclosures contained in this presentation, including such statistical, market and industry data, we have not independently verified any of the data from third-party sources, nor have we ascertained the underlying economic assumptions relied upon therein. In addition, while we believe the market opportunity information included in this presentation is generally reliable and is based on reasonable assumptions, the industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of important factors that could cause results to differ materially from those expressed in the estimates made by third parties and by us. In addition, trademarks used in this presentation are the property of their respective owners.

Offering Summary Issuer Symbol Securities offered Expected offering size Use of proceeds Sole book-running manager Lead manager Steakholder Foods Ltd. Nasdaq: STKH Up to 6,377,551 American Depositary Shares (each representing ten of our Ordinary Shares) or Pre-Funded Warrants to purchase American Depositary Share, and up to 6,377,551 Warrants to purchase American Depositary Shares. Approximately $12,500,000 + 15% over-allotment option We will use the net proceeds that we receive from the sale of the Securities offered for general corporate purposes, which may include operating expenses, working capital, future acquisitions or share repurchases, general capital expenditures and satisfaction of debt obligations. We have not determined the amount of net proceeds to be used specifically for such purposes. A.G.P. Maxim Group LLC

Using our proprietary 3D bio-printing technology and advanced biology, we are developing real meat from ethically harvested cells, that is designed to be delicious, nutritious, safe and consistent. 4

3D printing and incubation Steakholder Foods’ Core R&D High throughput 3D tissue engineering Multi-species cell-based manufacturing Advanced tissue engineering and differentiation capabilities

By making meat from animal cells, we are working to enable a growing global population to continue enjoying meat, while: preserving our ecosystems, keeping our food and fresh water secure, and protecting the welfare of animals. 6

Our impact Environmental impact 78%-96% less greenhouse gases 51%-78% less freshwater use 63%-95% less land use Social Impact Safe, controlled process, high-quality nutrition Strengthening local economies Slaughter-free food production Business impact Alignment with sustainable development goals and values Acceleration of industry collaboration More secure supply chain Sources: Tuomisto HL, de Mattos MJ. Environmental impacts of cultured meat production. Environ Sci Technol. 2011 Jul 15;45(14):6117-23; CE Delft: LCA of cultivated meat. Future projections for different scenarios, Feb 2021; UN Dept. Economic & Social Affairs.

Groupstructure Steakholder Innovation Ltd. 100% holdings Steakholder Foods Ltd. Peace of Meat BV 100% holdings Steakholder Foods USA, Inc. 100% holdings Steakholder Foods Europe BV 100% holdings

Companyhighlights 9

Companyhighlights Patent applications to date 18 Employees 80+ Raised to date $54M Of which 3 granted and one allowed. Several trade secrets identified 74% R&D 26% Other $34.5 million raised on Nasdaq in total

80+ Our team Employee geographic presence: Israel “headquarters” Belgium USA Our mission is to make real meat sustainable. Employees from over 20 countries

Management Yaron Kaiser Arik Kaufman Guy Hefer Dan Kozlovski Co-Founder and Chairman Co-Founder and CEO CFO CTO Avraham Hampel VP Corporate Development Eitan Noah VP Finance Orit Goldman, Ph.D. VP Biology Itamar Atzmony VP Engineering Yair Ayalon VP Business Development Mor Glotter-Nov VP Marketing Peter Bodenheimer Head of US Market

Meet our R&D experts Itamar Atzmony VP Engineering Dan Kozlovski CTO Orit Goldman, Ph.D. VP Biology Tal KalksteinSoftware Manager Timofey Shmal3D Printing Expert Shahar ZukranMechanical Engineer Moshe ManorElectrical & Software Engineer Matan LivneFPGA Embedded Developer Nadav Noor, Ph.D.Tissue Engineering Bio- Printing Manager Nelly Komarovsky, Ph.D.Mass Production Manager Nofar HarpazCell Isolation & Characterization Manager Yoni Moskovitz, Ph.D.Cellular Engineering Manager Dana Hillel Food Science Expert Tal KolekFood Science Expert Prof. Shlomo Magdassi Chemistry Advisor Prof. Tal Dvir Biology Advisor Advisors

Company Timeline September 2019 Company Initiates activities in Israel February 2021 Company acquires Peace of Meat, a leading Belgian developer of cultured avian products March 2021 Company raises $28M and becomes the first Nasdaq-listed cultivated meat company October 2021 Company partners with the BlueSoundWaves collective, led by Ashton KutcherGuy Oseary and Effie Epstein December 2021 Company prints the largest cultivated steak ever! 3.67 oz. February 2022 Company presents promising results with muscle cell differentiation into muscle fibers that better resemble those in whole cuts of meats April 2022 Company develops unique multi-nozzle 3D bioprinting system for highly precise industrial production at scale of cultivated meat May 2022 Peace of Meat signs joint development agreement with ENOUGH, a leader in mycoprotein May 2022 Company joins UN Global Compact June 2022 Company is granted its first patent for systems and methods to enhance muscle fiber formation: Issued by IP Australia July 2022 Company announces collaboration with Umami Meats, a Singaporean cultured seafood company September 2022 Company introduces Omakase Beef Morsels, a first-of-its-kind, highly marbled 3D-printed 100% cultured beef cut August 2020 Company accomplishes “Project Carpaccio”, bio-prints carpaccio-like sliced meat

Alternative protein market overview 15

Base case $20 billion in sales by 2030 High-growth scenario $25 billion in sales by 2030 Base case $450 billion in annual sales by 2040 High-growth scenario Market share of 20% by 2040 increasing to 40% by 2050 Base case $240 billion in salesMarket share of 9% by 2040 High-growth scenario $470 billion in salesMarket share of 18% by 2040 Huge market potential Source: Jefferies Equity research, September 2019. 16

Complexity Time Plant-based alternative products Cultivated hybrid products Thin tissue of premium cultivated meat Cultivated whole-cut premium meat Evolving alt-meatlandscape * All hybrid and cultivated images are Steakholder Foods' original visuals.

Technology overview 18

Cell source Cell production 3D bioprinting Printed Meat Incubation & Maturation Structured Product made by Steakholder Foods Fat Cells From cellsto foodThe journey Muscle fibers Fat Muscle Differentiation Hamburger made by Steakholder Foods Chicken nuggets made by Steakholder Foods Hybrid products Cultivated & plant-based

Structured Product made by Steakholder Foods From cellsto hybrid productsThe journey Fat Muscle Cell source 3D bioprinting Differentiation Printed Meat Incubation & Maturation Hamburger made by Steakholder Foods Chicken nuggets made by Steakholder Foods Muscle fibers Fat Cells Cell production Hybrid products Cultivated & plant-based

Cultivated & plant-based ingredients hybrid products First stopHybrid products 21

Cell source Cell production 3D bioprinting Hybrid products Cultivated & plant-based Printed Meat Incubation & Maturation Fat Muscle Differentiation Hamburger made by Steakholder Foods Chicken nuggets made by Steakholder Foods Fat Cells Muscle fibers From cellsto meatThe journey Structured Product made by Steakholder Foods

Fat Native Tissue Muscle Steakholder Foods Tissue 100 μm 100 μm 100 μm MHC Hoechst Phalloidin Bodipy Phalloidin Native muscle fiber structure Native Fat cell structure Bovine satellite cells derived muscle cells Bovine adipose stem cells derived fat cells The road to structured meat Differentiation Capabilities

Muscle Differentiation Maturation Before differentiation induction Day 7 of differentiation Day 14 of differentiation The road to structured meat Differentiation Capabilities

3D Bio-printing The road to structured meat Structured Products

Next stopPrintingreal meat End of 2021 achievement: Steakholder Foods’ 104-gram printed steak Sep. 2022 achievement: Steakholder Foods’ Omakase Beef Morsels

Physical manipulation of cultivated tissue Growth support for cell culture 1 Harvesting bovine embryonic inner cell mass Bioprinter printhead assembly Bovine umbilical cord stem cells as feeder layer 2 3 4 5 6 7 8 9 3D-printing high resolution support structures Muscle stem-cell fusing process Adipocytes differentiation using plant-based initiators Stacked multilayered beef-emulating portion Several trade secrets identified Steakholder Foods’ IP18 patent applications submitted (4 granted/allowed)

Strategy &business model 28

1 Species Structured meat Various Species Ground products Competitive landscape* * To the best of our knowledge, based on publicly-available information . 29

Building blocks for market penetration Scale & Cost Regulation USA EU Requires ‘novel food’ and food safety applications FDA moved toward initial approval of cultivated meat* Planned submission H2 2023 Planned submission H2 2023 Singapore Already approved cultured meat for sale in restaurants Planned submission H1 2023 * Upside Foods received a “No Questions” letter. * To the best of our knowledge, based on publicly-available information. ** CE Delft: TEA of cultivated meat Future projections of different scenarios (corrigendum.) Nov 2021 The first cultivated burger* ~$330,000 / (~140g) Created by Mark Post 2013 ~$2,360,000/kg * 2020 2030 Cost / Kg ~$20,000/kg ** ~$100/kg ** <$8/kg ** 2035

H1 H2 x SFA Regulatory Submission Animal-Free Growth Media and Bio-Ink Printing structured fish USDA & FDA Regulatory Submission 1st strategic bio-printer engagement Scale-up production initiation 2024 First Revenue Stream Main Activity Plan 2023 2023 2023 The capital raised will support these ongoing activities. 31

Go-To-Market Strategy Customers Steakholder Foods 3D bio-printer Aims to be the industry standard Plant-basedB2B  Manufacturers Plant-based & HybridB2B  Manufacturers & Distributors Cultivated Structured MeatB2B2C  Flexitarians Steakholder Foods Cultivated Whole Cut Meat Steakholder Foods Hybrid products Hamburgers, nuggets, etc. Products Steakholder Foods Cultivated Ingredients(Fat, Muscle, etc.) 2025 2024 2023 Cultivated Structured MeatB2B2C  Flexitarians 2026

Why Steakholder Foods? 2 3 5 6 4 Nasdaq public listing allows everyone to become a Steakholder Regulatory advancements in the USA (our first key target market) Leading brand name in the cultivated meat industry Low burn rate relative to technological and business development Highly differentiated value proposition leveraging engineering and 3D bio-printing capabilities 1 Advanced development and IP base, backed by numerous patent applications

Thank you

Appendices

($, millions) Sep 30, 2022 Current assets 12.1 Non current assets 21.1 Total assets 33.2 Current liabilities 5.6 Non current liabilities 3.2 Total liabilities 8.8 Equity 24.4 Total liabilities and equity 33.2 no bank debt and substantial IP R&D assets in cash and cash equivalents Investor deck_December22 Balance Sheet $ 11.2 m

Pre-Offering Capitalization Table Steakholder Foods Ltd. Ordinary shares ADS Equivalent Shares outstanding 140,384,407 14,038,441 Options and Restricted Share Units 28,828,262 2,882,826 Warrants 44,865,621 4,486,562 Rights 1,407,466 140,747 Fully diluted shares outstanding 215,485,756 21,548,576 As of December 5, 2022